Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (51-60 of 377) with videos related to

Pageof 38
Sort By:
Journal of Hematotherapy & Stem Cell Research|July 15, 2003
Unrelated donor transplantation after reduced intensity conditioning as an approach for patients lacking related donors for allogeneic stem cell transplantationSabine Hoepfner, Martin Goerner, Axel Benner, et al.
British Journal of Haematology|August 6, 2003
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemiaManfred Hensel, Martin Kornacker, Sophie Yammeni, et al.
European Journal of Haematology|February 24, 2011
Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemiaAleksandar Radujkovic, Frauke Bellos, Mindaugas Andrulis, et al.
Leukemia & Lymphoma|March 23, 2002
Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemiaJolanta Perz, Julian Topaly, Stefan Fruehauf, et al.
Clinical Lymphoma & Myeloma|October 20, 2005
Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphomaManfred Hensel, Matthias Villalobos, Martin Kornacker, et al.
Experimental Hematology|May 29, 2002
Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cellsMichael Punzel, Tao Zhang, Daihong Liu, et al.
Acta Ophthalmologica|July 17, 2009
Intravitreal autologous bone-marrow-derived mononuclear cell transplantationJost B Jonas, Mathias Witzens-Harig, Lubomir Arseniev, et al.
Leukemia & Lymphoma|April 10, 2008
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myelomaChristian Frank, Michael Hundemer, Anthony D Ho, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 23, 2015
Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac DiseasesSarah Rohlfing, Matthias Aurich, Tilman Schöning, et al.
Scientific Reports|July 15, 2018
Simple Physical Model Unravels Influences of Chemokine on Shape Deformation and Migration of Human Hematopoietic Stem CellsTakao Ohta, Cornelia Monzel, Alexandra S Becker, et al.
Pageof 38

Showing results (51-60 of 377) with videos related to

Sort By:
Pageof 38
Journal of Hematotherapy & Stem Cell Research|July 15, 2003
Unrelated donor transplantation after reduced intensity conditioning as an approach for patients lacking related donors for allogeneic stem cell transplantationSabine Hoepfner, Martin Goerner, Axel Benner, et al.
British Journal of Haematology|August 6, 2003
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemiaManfred Hensel, Martin Kornacker, Sophie Yammeni, et al.
European Journal of Haematology|February 24, 2011
Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemiaAleksandar Radujkovic, Frauke Bellos, Mindaugas Andrulis, et al.
Leukemia & Lymphoma|March 23, 2002
Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemiaJolanta Perz, Julian Topaly, Stefan Fruehauf, et al.
Clinical Lymphoma & Myeloma|October 20, 2005
Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphomaManfred Hensel, Matthias Villalobos, Martin Kornacker, et al.
Experimental Hematology|May 29, 2002
Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cellsMichael Punzel, Tao Zhang, Daihong Liu, et al.
Acta Ophthalmologica|July 17, 2009
Intravitreal autologous bone-marrow-derived mononuclear cell transplantationJost B Jonas, Mathias Witzens-Harig, Lubomir Arseniev, et al.
Leukemia & Lymphoma|April 10, 2008
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myelomaChristian Frank, Michael Hundemer, Anthony D Ho, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 23, 2015
Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac DiseasesSarah Rohlfing, Matthias Aurich, Tilman Schöning, et al.
Scientific Reports|July 15, 2018
Simple Physical Model Unravels Influences of Chemokine on Shape Deformation and Migration of Human Hematopoietic Stem CellsTakao Ohta, Cornelia Monzel, Alexandra S Becker, et al.
Pageof 38